Engineers Gate Manager LP Harpoon Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $122,904 - $169,128	-21,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $26,634 - $47,320	3,380 Added 18.55%	21,600 $171,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $251,618 - $423,615	18,220 New	18,220 $253,000
Q3 2020 Nov 16, 2020	SELL	$11.01 - $18.52 $110,364 - $185,644	-10,024 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$11.11 - $24.72 $111,366 - $247,793	10,024 New	10,024 $166,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.